Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands
Authors:
- O. de WeerdtOWO. de Weerdt
- D.H. BiesmaDBD.H. Biesma
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Preventing severe infection after splenectomyBMJ, 2005
- Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal PolysaccharidesClinical and Vaccine Immunology, 2003
- Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleenClinical Medicine, 2002
- Prevention of overwhelming sepsis in asplenic patients: could do betterThe Lancet, 2001
- Overwhelming infection in asplenic patients: current best practice preventive measures are not being followedJournal of Clinical Pathology, 2001
- Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: AppendixBMJ, 1996
- A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodiesJournal of Immunological Methods, 1993
- Role of Cell Wall Polysaccharide in the Assessment of IgG Antibodies to the Capsular Polysaccharides of Streptococcus pneumoniae in ChildhoodThe Journal of Infectious Diseases, 1992
- Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharideJournal of Immunological Methods, 1992
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1983